169303 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Method for identifying compounds that modulate a T2R taste receptor
#1502Engineered thioredoxin-like fold proteins
#1503Organ-Specific Proteins and Methods of Their Use
#1504Stabilized bioactive peptides and methods of identification, synthesis, and use
#1505NON-PEPTIDE AGONISTS AND ANTAGONISTS OF ADRENOMEDULLIN AND GASTRIN RELEASING PEPTIDE
#1506ANTI-DDR1 ANTIBODIES
#1507Serum S100B And Uses Thereof
#1508Methods of evaluating peptide mixtures
#1509Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides
#1510Method for identifying gambiered guangdong silk
#1511Systems and methods for determining a C-peptide receptor, C-peptide receptor, and methods of using same
#1512High-affinity monoclonal anti-prion antibodies
#1513Methods and compositions for highly sensitive detection of molecules
#1514Systems and methods for characterization of molecules
#1515Isoltation of Factors Associated with Nucleic Acid
#1516Methods for determining ligand binding to a target protein using a thermal shift assay
#1517Method for Measuring Glycoprotein, Method for Examining Liver Desease, Reagent for Quantitative Determination of Glycoprotein and Glycan-Marker Glycoprotein as an Index for Clinical Conditions of Liver Disease
#1518POLYNUCLEOTIDE BASE SEQUENCE DETERMINATION METHOD AND POLYNUCLEOTIDE BASE SEQUENCE DETERMINATION DEVICE
#1519Modulators of alpha-synuclein toxicity
#1520Devices, systems, and methods for aiding in the detection of a physiological abnormality
#1521Thyroglobulin quantitation by mass spectrometry
#1522Non-surgical method of treatment for cataract
#1523Yeast cell surface display of proteins and uses thereof
#1524Methods of detecting therapeutic exosomes
#1525ANTIHUMAN BAFF ANTIBODY
#1526IDENTIFICATION OF A NOVEL HUMAN POLYOMAVIRUS (IPPyV) AND APPLICATIONS
#1527Non-antagonistic EGFR-binding molecules and immunoconjugates thereof
#1528Bridge-helix cap: target and method for inhibition of bacterial RNA polymerase
#1529Methods of evaluating diethylamide in peptide mixtures for the preparation of glatiramer acetate
#1530Automatic injection device for microarray chip and automatic injection hybridization microarray chip
#1531Insecticidal proteins and methods for their use
#1532cMET protein SRM/MRM assay
#1533Secretory Protein Biomarkers For High Efficiency Protein Expression
#1534Agent for treating allergic or hypersensitivity condition
#1535Filtration methods and devices
#1536Method for measuring cardiac troponin
#1537Flow cytometry analysis of materials adsorbed to metal salts
#1538Sumoylation Control Agent and Uses Thereof
#1539Assays and methods to sequence microbes directly from immune complexes
#1540Factors controlling skin and hair color
#1541Granzyme A and granzyme B diagnostics
#1542GROWTH HORMONE RECEPTOR DEFICIENCY CAUSES A MAJOR REDUCTION IN PRO-AGING SIGNALING, CANCER AND DIABETES IN HUMANS
#1543Process and kit for determining in vitro the immune status of an individual
#1544Expression of secreted and cell-surface polypeptides
#1545Detection of nucleic acids and proteins
#1546N-METHYLPURINE DNA GLYCOSYLASE AND POLYMERASE BETA AS BIOMARKERS FOR ALKYLATOR CHEMOTHERAPY POTENTIATION
#1547MULTICOMPARTMENTALIZED VESICULAR STRUCTURE AND A METHOD FOR FORMING THE SAME
#1548BIOMARKERS FOR PROSTATE CANCER AND METHODS USING THE SAME
#1549Use of heat-resistant biotin-binding protein, and solid support having the protein attached thereto
#1550Method for evaluating regenerated cartilage
#1551Static magnetic field induced differential fluorescence emission
#1552Method of determining administration effect in cancer chemotherapy with S-1
#1553Highly sensitive system and method for analysis of troponin
#1554METHODS FOR DETECTING ALLOSTERIC MODULATORS OF PROTEIN
#1555Method for detecting compounds containing sulfenic acid using a 1,3-cyclohexanedione-based probe
#1556Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases
#1557Monitoring of neuromodulation using biomarkers
#1558Selection of medicaments that modulate the function and activity of interleukin 13
#1559Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
#1560METHOD OF DETECTING CALCIFYING NANOPARTICLES AND SUSCEPTIBILITY TO CALCIFYING NANOPARTICLE FORMATION
#1561Serological Markers of Inflammatory Bowel Disease Phenotype and Disease Progression
#1562Marker and reagent for detection of human IL-17-producing helper T cells, and method for detection of human IL-17-producing helper T cells
#1563Methods for isolation, use and analysis of ferritin
#1564Compounds and methods
#1565TFPI inhibitors and methods of use
#1566Interrogatory cell-based assays and uses thereof
#1567Apparatus and method for molecular separation, purification, and sensing
#1568PYRIDINONE ANTAGONISTS OF ALPHA-4 INTEGRINS
#1569TARGETING MTOR SUBSTRATES IN TREATING PROLIFERATIVE DISEASES
#1570Fibronectin binding domains with reduced immunogenicity
#1571NUCLEIC ACID CONSTRUCT AND COMPLEX FORMATION METHOD AND SCREENING METHOD USING THE SAME
#1572Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases
#1573System for molecular packing calculations
#1574Biomarker sampling in the context of neuromodulation devices, systems, and methods
#1575SOLUBLE HLA CLASS II COMPLEXES AND METHODS OF PRODUCTION AND USE THEREOF
#1576Use of quinolinone derivatives as a research tool
#1577Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-tRNA synthetases
#1578Novel Peptide Involved in Energy Homeostasis
#1579Methods for monitoring methotrexate therapy
#1580Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
#1581Compositions comprising engineered phosphothreonine affinity reagents, methods of making, and methods of use
#1582METHOD FOR PREDICTION OF RESPONSE TO IMMUNE MEDIATED DISEASE THERAPEUTICS
#1583Method for enrichment and isolation of endogenous transcription factor and complexes thereof and corresponding tandem arrays of concatenated transcription factor response elements
#1584Method for recognizing interferences in in vitro diagnostic assays
#1585Methods and materials for assessing responsiveness to PARP inhibitors and platinating agents
#1586Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
#1587Methods Of Determining Skeletal Maturity
#1588Protein melt analysis using dipyrrometheneboron difluoride compounds
#1589Auto-developing and regularly-weighted protein molecular weight marker kit and method for preparing the same
#1590Method for controlling hair growth, method for selecting or evaluating hair growth control agent, and hair growth suppression agent
#1591Markers of the male urogenital tract
#1592Analyte mass spectrometry quantitation using a universal reporter
#1593METHODS AND COMPOSITIONS FOR STIMULATING A FELIDAE T1R RECEPTOR
#1594Immunogenic compositions comprising polypeptides and fusions thereof
#1595Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
#1596INHIBITORS OF PDE4 BINDING TO HSP20
#1597ISOLATION OF ADULT MULTIPOTENTIAL CELLS BY TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE
#1598METHOD FOR DECISION SUPPORT IN ALLERGY DIAGNOSIS
#1599Thyroglobulin quantitation by mass spectrometry
#1600Lectin Assay for Assessing Glycoforms as an Early Marker in Disease
#1601Biomarkers of immunomodulatory effects in humans treated with anti-CD200 antibodies
#1602INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF HISTIDYL-TRNA SYNTHETASES
#1603Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
#1604Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Valyl-tRNA synthetases
#1605BNIP3 ISOFORMS AND METHODS OF USE
#1606Fibronectin binding domains with reduced immunogenicity
#1607EX VIVO PLASMA ENZYME ACTIVITY ASSAY USING INHIBITORS AS A NEGATIVE CONTROL
#1608Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
#1609Analyzing spectra
#1610Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said Treatment
#1611Direct clone analysis and selection technology
#1612Detection of human umbilical cord tissue derived cells
#1613Nucleic acids encoding T2R bitter taste receptors
#1614Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of chronic kidney disease and symptoms and/or complications thereof
#1615Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof
#1616Method and compositions for the detection of protein glycosylation
#1617High affinity binding site of HGFR and methods for identification of antagonists thereof
#1618METHODS OF DIAGNOSING NON-ALCOHOLIC STEATOHEPATITIS (NASH)
#1619Detection and measurement of blood-feeding activity
#1620Apparatus for disease detection
#1621Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#1622Systems and methods for single-molecule detection using nanopores
#1623Aza-benzazolium containing cyanine dyes
#1624PROTEIN PRODUCTION
#1625Pharmaceutical compositions including a portion of the C-terminus of FGF23
#1626Method of drug design
#1627Broad spectrum influenza A neutralizing vaccines and D-peptidic compounds, and methods for making and using the same
#1628Prostaglandin transporter inhibitors
#1629Imidazolium salts and carbene metal complexes based thereon for use as bioanalytical markers for biomolecules
#1630SAPP-ALPHA AS A BIOMARKER FOR PREDICTION OF INFLAMMATORY AND AUTOIMMUNE-RELATED DISORDERS
#1631Biomarkers for determination of temporal phase of acute kidney injury
#1632Methods of detection of species in bodily fluid
#1633Accurate measurement of glutathione for disease diagnosis and drug metabolite screening
#1634System for glycated protein detection
#1635LTBP2 AS A BIOMARKER FOR EVALUATING THE RISK OF DEATH IN A DISEASED SUBJECT
#1636Anticancer composition
#1637Monoclonal antibody against group 2 allergen of , hybridoma cell line producing thereof, strip, kit and method using said monoclonal antibody for dust mite assay
#1638PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#1639DIAGNOSTIC TEST TO EXCLUDE SIGNIFICANT RENAL INJURY
#1640Integrin heterodimer and a subunit thereof
#1641Compositions and Methods for Treating Pulmonary Conditions
#1642Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues
#1643METHOD TO DETECT AND TREAT INFECTIOUS OR INFLAMMATORY DIARRHEA BASED ON REG1
#1644METHODS FOR ASSESSING THE IMMUNE SYSTEM IN A PATIENT
#1645Magnetic immunodiagnostic methods and kit for the demonstration of antibody/antigen complexes in erythrocyte blood grouping and phenotyping
#1646Monoclonal antibodies to human immunodeficiency virus and uses thereof
#1647Bilayers
#1648Method for the characterization of intermolecular interactions
#1649Process for Ensuring Consistency and Reproducibility of a Diagnostic or Research Method
#1650Tango 240 nucleic acids and uses thereof
#1651Methods for ionophorically screening pore forming bacterial protein toxins and receptors
#1652Methods and compositions for labeling polypeptides
#1653Methods for enriching for pancreatic endocrine cells
#1654Method for treating cancer with agents that bind phosphorylated CDC27
#1655METHOD FOR SELECTION OF CHEMOTHERAPEUTIC AGENTS FOR ADENOCARCINOMA CANCER
#1656METHOD FOR SELECTION OF CHEMOTHERAPEUTIC AGENTS FOR ADENOCARCINOMA CANCER
#1657Ubiquitination assay
#1658PEPTIDE PROBES FOR DIAGNOSTICS AND THERAPEUTICS
#1659Analyte mass spectrometry quantitation using a universal reporter
#1660Sperm-specific cation channel, CatSper1 and uses therefor
#1661Methods of treating cancer using chemovirotherapy
#1662MODULATORS AND MODULATION OF THE INTERACTION BETWEEN RGM AND NEOGENIN
#1663leukocidins, therapeutic compositions, and uses thereof
#1664High-resolution analysis devices and related methods
#1665Protein Modification from the Oxidation of Clickable Polyunsaturated Fatty Acid Analogs
#1666GLP-1 receptor agonist bioassay
#1667Monoclonal antibodies against HER2 antigens, and uses therefor
#1668Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
#1669METHODS AND COMPOSITIONS COMPRISING AMPK ACTIVATOR (METFORMIN/TROGLITAZONE) FOR THE TREATMENT OF MYOTONIC DYSTROPHY TYPE 1 (DM1)
#1670Immunoassay for chromogranin A, antibodies and kit
#1671Method of identifying transmembrane protein-interacting compounds
#1672IGF-1R SPECIFIC ANTIBODIES USEFUL IN THE DETECTION AND DIAGNOSIS OF CELLULAR PROLIFERATIVE DISORDERS
#1673Methods and kits for determining von Willebrand factor activity in the absence of ristocetin and for determining the activity of ADAMTS-13 protease
#1674Fc receptor binding proteins
#1675Fibronectin aggrecan biomarker for the identification of spinal and joint source of pain
#1676Secreted protein acidic and rich in cysteine (SPARC) protein SRM assay
#1677Sulfur-containing amino acid derivative
#1678Kit for detecting Cthrc1 in a sample
#1679Anti-polyubiquitin antibodies
#1680CELL FREE TRANSLATION SYSTEM FOR COMPOUND SCREENING AND RELATED USES
#1681CHIP FOR PROTEIN DETECTION, METHOD FOR MANUFACTURING THE SAME, AND METHOD FOR DETECTING PROTEIN BY USING THE SAME
#1682CD4 T-cells and CD8zeta cells involved in mammalian host response to epithelial cell infections and uses thereof
#1683Methods for identifying and using organ-specific proteins in blood
#1684FC RECEPTOR BINDING PROTEINS
#1685CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS CLUMPING FACTOR A IN COMPLEX WITH FIBRINOGEN DERIVED PEPTIDE AND USES THEREOF
#1686ISOLATED MAMMALIAN MONOCYTE CELL GENES; RELATED REAGENTS
#1687Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#1688BIOLOGICALLY ACTIVE PEPTIDOMIMETIC MACROCYCLES
#1689PROTEIN FRAGMENT COMPLEMENTATION ASSAYS FOR THE DETECTION OF BIOLOGICAL OR DRUG INTERACTIONS
#1690Methods and Compositions for Regulating Musashi Function
#1691Method for integrin ligand discovery
#1692Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
#1693ANTIBODIES TO CONFORMATIONALLY TRAPPED PROTEINS
#1694TESTING LUMENECTOMY SAMPLES FOR MARKERS OF NON-VASCULAR DISEASES
#1695Solid phase-bound elastase-binding assay for the measurement of alpha-antitrypsin activity
#1696Method for determining the binding constant of high affinity compounds
#1697METHOD OF ANALYZING HUMAN sCD14-ST
#1698MULTIPROTEIN ASSEMBLIES
#1699SGEF CONTROLS MACULAR, CORPUS CALLOSUM AND HIPPOCAMPAL FUNCTION AND DEVELOPMENT, LIVER HOMEOSTASIS, FUNCTIONS OF THE IMMUNE SYSTEM, FEVER RESPONSE ATHEROSCLEROSIS AND TUMOROGENIC CELL GROWTH
#1700Aza-benzazolium Containing Cyanine Dyes
#1701HIGHLY CONCENTRATED DRUG PARTICLES, FORMULATIONS, SUSPENSIONS AND USES THEREOF
#1702METHODS AND PRODUCTS RELATED TO THE IMPROVED ANALYSIS OF CARBOHYDRATES
#1703Methods of identifying inhibitors of FGF23 binding to the binary FGFR-klotho complex for the treatment of hypophosphatemia
#1704METHODS FOR IMPROVING THE DESIGN, BIOAVAILABILITY, AND EFFICACY OF DIRECTED SEQUENCE POLYMER COMPOSITIONS VIA SERUM PROTEIN-BASED DETECTION OF DIRECTED SEQUENCE POLYMER COMPOSITIONS
#1705Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
#1706Measurement of an analyte on the skin using a hue angle
#1707Methods predicting risk of an adverse clinical outcome
#1708Serum protein-based detection of random sequence polymer compositions
#1709HUMAN TRANSMEMBRANE PROTEINS
#1710Peptides and aptamers thereof as specific modulators of mutant p53 function
#1711Methods for voltage-induced protein incorporation into planar lipid bilayers
#1712Method and system for polypeptide purification
#1713METHODS FOR ASSESSING RISK OF BONE FRACTURE
#1714CHARACTERIZATION OF MOLECULES
#1715Methods Of Determining Skeletal Maturity
#1716MCAM as a biomarker for fluid homeostasis
#1717ASSAYS FOR INFLUENZA VIRUS HEMAGGLUTININS
#1718SCD Fingerprints
#1719NON-PEPTIDE ANTAGONISTS OF GASTRIN RELEASING PEPTIDE
#1720Hair shape susceptibility gene
#1721Markers for the diagnosis of celiac disease
#1722Methods for identifying inhibitors of mannan-binding lectin associated serine protease (MASP) proteins and uses thereof
#1723Methods of treating diseases
#1724BIOMARKER FOR DIAGNOSIS, PREDICTION AND/OR PROGNOSIS OF ACUTE HEART FAILURE AND USES THEREOF
#1725METHODS FOR PROTECTING DOPAMINERGIC NEURONS FROM STRESS AND PROMOTING PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTE PROGENITORS BY NRG-2
#1726Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
#1727Method of calculating a phosphorus-protein ratio
#1728Serum markers associated with early and other stages of breast cancer
#1729Diagnosis of depression
#1730METHOD FOR ISOLATING NUCLEIC ACIDS AND PROTEIN FROM A SINGLE SAMPLE
#1731Method for measuring glycoprotein, method for examining liver disease, reagent for quantitative determination of glycoprotein, and glycan-marker glycoprotein as an index for clinical conditions of liver disease
#1732Method of detection using antibodies that specifically bind hedgehog-derived polypeptides
#1733GENES AND USES FOR PLANT IMPROVEMENT
#1734METHODS OF INHIBITING THE ACTIVITY OF HSP90 AND/OR ARYL HYDROCARBON RECEPTOR
#1735Method of screening a substance for improving insulin resistance
#1736Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
#1737Methods for ionophorically screening pore forming bacterial protein toxins and receptors
#1738Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders
#1739Integrin Heterodimer And A Subunit Thereof
#1740Artificial antibody polypeptides
#1741Quality control bioassays for nutriceutical and medicinal products
#1742Methods and compositions for targeting polyubiquitin
#1743MARKER AND REAGENT FOR DETECTION OF HUMAN IL-17-PRODUCING HELPER T CELLS, AND METHOD FOR DETECTION OF HUMAN IL-17-PRODUCING HELPER T CELLS
#1744COMPOSITION FOR ASSAYING GLYCATED PROTEINS
#1745TESTING LUMENECTOMY SAMPLES FOR MARKERS OF NON-VASCULAR DISEASES
#1746HIGH THROUGHPUT APPROACH TO FORMULATION USING PRE-DESIGNED FORMULATION PLATES
#1747High affinity binding site of HGFR and methods for identification of antagonists thereof
#1748MARKED PEPTIDES AND USE THEREOF FOR ASSAYING CIRCULATING IRAP
#1749Method for treating cancer or cancer metastasis
#1750MONOCLONAL ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS AND USES THEREOF
#1751Systems and methods for collecting tear film and measuring tear film osmolarity
#1752SYSTEMS AND METHODS FOR CHARACTERIZATION OF MOLECULES
#1753Organ-specific proteins and methods of their use
#1754Methods of diagnosing ALS
#1755METHOD TO INHIBIT THE BIOLOGICAL ACTIVITY OF CALCINEURIN WITH SELECTIVE PEPTIDES
#1756Phosphodiesterase 4D7 as prostate cancer marker
#1757Stabilized bioactive peptides and methods of identification, synthesis, and use
#1758Drug target that promotes secretory granule-granule fusion
#1759ANTI- INTEGRIN ANTIBODIES, COMPOSITIONS, METHODS AND USES
#1760Method for Introducing Protein and/or Peptide Into Cell
#1761METHOD FOR DEMONSTRATION OF A MOLECULAR EVENT IN A CELL BY MEANS OF FLUORESCENT MARKER PROTEINS
#1762TFPI inhibitors and methods of use
#1763ISOLATED MAMMALIAN MONOCYTE CELL GENES; RELATED REAGENTS
#1764METHODS AND COMPOSITIONS FOR POLYPEPTIDE ENGINEERING
#1765Thyroglobulin quantitation by mass spectrometry
#1766Nucleic acid encoding a T2R taste receptor
#1767ENRICHMENT AND PURIFICATION OF INFECTIOUS PRION PROTEINS
#1768Renal cell carcinoma biomarkers
#1769Anti-human equilibrative nucleoside transporter 1 (hENT1) antibodies and methods of use thereof
#1770POLYPEPTIDE STRUCTURAL MOTIFS ASSOCIATED WITH CELL SIGNALING ACTIVITY
#1771CELLS FOR INDICATING THE PRESERVATION OF BIOLOGICAL SAMPLES
#1772Hsp9O-targeted anti-cancer chimeric peptide
#1773Molecule
#1774Compositions and methods for treatment of neurodegenerative diseases
#1775Aptamer and detection method for C-reactive protein
#1776Arginine vasopressin pro-hormone as predictive biomarker for diabetes
#1777Methods and kits for predicting a response to an erythropoietic agent
#1778Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
#1779METHODS AND KITS FOR SCREENING PROTEIN SOLUBILITY
#1780Composition for assaying glycated proteins
#1781Use of leptin to treat metabolic abnormalities associated with lipoatrophy
#1782NANOPARTICLE FOR BIOAFFINITY ASSAYS
#1783ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN
#1784Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
#1785Protein fragment complementation assays for the detection of biological or drug interactions
#1786Tethered Conformation Capture
#1787Synthetic peptides, methods and kits for diagnosing autoimmune diseases
#1788METHOD OF IDENTIFYING COMPOUNDS THAT MODULATE REGULATION OF IRON RESPONSE ELEMENTS
#1789Methods and kits for detecting misfolded proteins
#1790Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
#1791Use of precursors of tachykinins and/or their fragments in medical diagnostic
#1792leukocidins, therapeutic compositions, and uses thereof
#1793LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN
#1794TARGET PROTEIN AND TARGET GENE FOR DRUG DISCOVERY, AND SCREENING METHOD
#1795METHODS FOR CLASSIFYING SAMPLES BASED ON NETWORK MODULARITY
#1796Anti-polyubiquitin antibodies and methods of use
#1797Monoclonal antibodies against HER2 antigens, and uses therefor
#1798TESTING LUMENECTOMY SAMPLES FOR MARKERS OF NON-VASCULAR DISEASES
#1799N-METHYLPURINE DNA GLYCOSYLASE AND POLYMERASE BETA AS BIOMARKERS FOR ALKYLATOR CHEMOTHERAPY POTENTIATION
#1800Method for detecting human BPLP protein or a maturation product thereof